Novel .DELTA..sup.4 -androstenes

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

26039745, 2603975, 26023955R, C07J 100

Patent

active

042320151

ABSTRACT:
Novel .DELTA..sup.4 -androstenes of the formula ##STR1## wherein R.sub.1 is alkyl of 1 to 3 carbon atoms, R' is an acyl of an organic carboxylic acid or carbonic acid of 1 to 18 carbon atoms, R.sub.2 is selected from the group consisting of alkyl of 1 to 12 carbon atoms, alkenyl of 2 to 12 carbon atoms, --CF.sub.3, aryl of 6 to 12 carbon atoms and aralkyl of 7 to 12 carbon atoms, Y is selected from the group consisting of hydrogen, fluorine and methyl, X is selected from the group consisting of hydrogen, chlorine, bromine and fluorine and the dotted lines in the A and B rings indicate one or 2 double bonds in 1(2) and 6(7) positions with the proviso when R.sub.1 is methyl and the B ring is saturated, X is hydrogen when Y is hydrogen and X is not hydrogen when Y is fluorine having a remarkable anti-inflammatory activity and their preparation.

REFERENCES:
patent: 3442918 (1969-05-01), Feather et al.
patent: 4168306 (1979-09-01), Teutsch et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Novel .DELTA..sup.4 -androstenes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel .DELTA..sup.4 -androstenes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel .DELTA..sup.4 -androstenes will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1645419

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.